Evidence map›Paper›PMID 42143038›Full record

ArticleNature communications2026

De novo design of peptides localizing at the interface of biomolecular condensates.

Timo N Schneider, Marcos Gil-Garcia, Marco A Bühler, Lucas F Santos, Lenka Faltova, Gonzalo Guillén-Gosálbez, Paolo Arosio

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Timo N SchneiderDepartment of Chemistry and Applied Biosciences, Institute for Chemical and Bioengineering, ETH Zurich, Zurich, Switzerland.ORCID http://orcid.org/0000-0002-8989-1406
Marcos Gil-GarciaDepartment of Chemistry and Applied Biosciences, Institute for Chemical and Bioengineering, ETH Zurich, Zurich, Switzerland.ORCID http://orcid.org/0000-0002-7457-7860
Marco A BühlerDepartment of Chemistry and Applied Biosciences, Institute for Chemical and Bioengineering, ETH Zurich, Zurich, Switzerland.ORCID http://orcid.org/0009-0002-5323-5957
Lucas F SantosDepartment of Chemistry and Applied Biosciences, Institute for Chemical and Bioengineering, ETH Zurich, Zurich, Switzerland.ORCID http://orcid.org/0000-0001-5931-4272
Lenka FaltovaDepartment of Chemistry and Applied Biosciences, Institute for Chemical and Bioengineering, ETH Zurich, Zurich, Switzerland.
Gonzalo Guillén-GosálbezDepartment of Chemistry and Applied Biosciences, Institute for Chemical and Bioengineering, ETH Zurich, Zurich, Switzerland.ORCID http://orcid.org/0000-0001-6074-8473
Paolo ArosioDepartment of Chemistry and Applied Biosciences, Institute for Chemical and Bioengineering, ETH Zurich, Zurich, Switzerland. paolo.arosio@chem.ethz.ch.ORCID http://orcid.org/0000-0002-2740-1205

Funding

EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council) 101002094
6 · The paper itself

Abstract

The interface of biomolecular condensates plays a key role in processes such as protein aggregation and biochemical reactions, making it an attractive target for engineering condensates. However, the molecular grammar that drives preferential localization to condensate interfaces remains poorly understood. Here, we develop a computational pipeline that integrates high-throughput coarse-grained simulations, machine learning, and mixed-integer linear programming to design peptides that partition at the interfaces of defined condensate targets. We validated the workflow by designing and synthesizing peptides that localize at the interface of three distinct condensates formed by intrinsically disordered protein regions. These peptides exhibit surfactant-like architectures. Specifically, one tail inserts into the condensate and is enriched in aromatic residues, while the opposite tail is excluded from the dense phase, with its sequence varying according to the scaffold's net charge. Overall, our pipeline offers a general strategy for rationally designing interface-localizing peptides and for unraveling the governing design principles.

Indexed as

Biomolecular CondensatesIntrinsically Disordered ProteinsPeptidesAmino Acid SequenceMachine LearningIntrinsically Disordered ProteinsPeptides

Identifiers

PMID42143038
PMCPMC13376736

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.